Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Stocks held by Nippon India Pharma Fund

#Stock NamePrevious Number of Shares ▲▼Previous Date ▲▼Current Number of Shares ▲▼Percentage Change ▲▼Last Changed ▲▼
1Mankind Pharma Ltd1,154,1412024-11-22900,794-21.95%2024-11-23
2Abbott India Ltd42,3102024-11-2276,39080.55%2024-11-23
3Torrent Pharmaceuticals Ltd2,309,2532024-11-21603,364-73.87%2024-11-23
4Thyrocare Technologies Ltd321,9032024-11-221,765,838448.56%2024-11-23
5Sun Pharmaceuticals Industries Ltd6,434,0092024-11-216,556,3491.90%2024-11-23
6Sanofi India Ltd196,3422024-11-21236,00820.20%2024-11-23
7Pfizer Ltd947,9102024-11-21293,249-69.06%2024-11-23
8Orchid Pharma Ltd175,0002024-11-221,000,000471.43%2024-11-23
9Narayana Hrudayalaya Ltd300,0002024-11-211,849,571516.52%2024-11-23
10Jubilant Pharmova Ltd8272024-11-22550,33966,446.43%2024-11-23
11J B Chemicals & Pharmaceuticals Ltd701,3842024-11-221,486,868111.99%2024-11-23
12Indoco Remedies Ltd276,8512024-11-221,834,924562.78%2024-11-23
13Healthcare Global Enterprises Ltd20,0002024-11-22400,4321,902.16%2024-11-23
14Glaxosmithkline Pharmaceuticals Ltd753,2572024-11-21853,90713.36%2024-11-23
15Gland Pharma Ltd2,047,1142024-11-221,500,000-26.73%2024-11-23
16Dr Reddys Laboratories Ltd1,126,0532024-11-21550,030-51.15%2024-11-23
17Dr Lal Pathlabs Ltd529,7302024-11-21425,000-19.77%2024-11-23
18Astrazeneca Pharma India Ltd5,6672024-11-2211,561104.01%2024-11-23
19Apollo Hospitals Enterprise Ltd625,0002024-11-22648,7953.81%2024-11-23
20Alkem Laboratories Ltd472,2182024-11-21377,412-20.08%2024-11-23
21Ajanta Pharma Ltd674,3732024-11-21968,21443.57%2024-11-23

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.